Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens00On May 28, 2018May 28, 2018By BSIIn User PublicationsTernette, N., et al. Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens. Proteomics. e1700465. 28/5/2018.
Leave a Reply